
Tennessee’s attorney general said he would look into whether the live-events site Ticketmaster violated consumers’ rights and antitrust regulations, after glitches on the platform during the sale of tickets for Taylor Swift’s “Eras” tour left some fans stranded in hours-long virtual queues.
Jonathan Skrmetti (R) said his office had received complaints from people who tried purchasing tickets for “Eras,” Swift’s first tour in over four years, and said they faced a chaotic process and a “severe lack of customer support” from Ticketmaster. It was not clear Thursday morning whether the attorney general has opened a formal investigation.
Related: Ocasio Cortez Calls For Breakup Of Ticketmaster
“We are concerned about this very dominant market player, and we want to make sure that they’re treating consumers right and that people are receiving a fair opportunity to purchase the tickets that clearly matter a great deal to them,” Skrmetti said of Ticketmaster during a Wednesday news conference, according to a transcript provided by his office.
“We just need to take a closer look,” he added.
The chaos over sales of Swift tickets caused some politicians to raise questions about the 2010 merger between Ticketmaster and the event company Live Nation, amid allegations from consumer rights groups that the company abused its dominant position in the market. Skrmetti, who said his office had “previously looked into antitrust allegations involving Ticketmaster and Live Nation,” stressed that neither company has been accused of misconduct.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas